Cargando…
Formulation and Intracellular Trafficking of Lipid–Drug Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug for Improved Intracellular Delivery to Human Macrophages
[Image: see text] Isoniazid is an important first-line antitubercular drug used in the treatment of all major clinical manifestations of tuberculosis, including both pulmonary and cerebral diseases. However, it is associated with significant drawbacks due to its inherent hydrophilic nature, includin...
Autores principales: | Pandit, Sayantan, Roy, Subhadeep, Pillai, Jonathan, Banerjee, Subham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066568/ https://www.ncbi.nlm.nih.gov/pubmed/32175491 http://dx.doi.org/10.1021/acsomega.9b03523 |
Ejemplares similares
-
Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017) -
Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer
por: Yoon, Dennis J., et al.
Publicado: (2011) -
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
por: Ritchie, Michael, et al.
Publicado: (2013) -
Intracellular Trafficking Network and Autophagy of PHBHHx Nanoparticles and their Implications for Drug Delivery
por: Sun, Xiangyu, et al.
Publicado: (2019) -
Lipid-drug conjugates: a potential nanocarrier system for oral drug delivery applications
por: Banerjee, Subham, et al.
Publicado: (2018)